Barlow JL - Search Results

1

Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Camelo A, Barlow JL, Drynan LF, Neill DR, Ballantyne SJ, Wong SH, Pannell R, Gao W, Wrigley K, Sprenkle J, McKenzie AN. Camelo A, et al. Among authors: barlow jl. J Gastroenterol. 2012 Nov;47(11):1198-211. doi: 10.1007/s00535-012-0591-2. Epub 2012 Apr 27. J Gastroenterol. 2012. PMID: 22539101 Free PMC article.

2

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion.

Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, Hewett DR, McIlgorm A, Jolin HE, McKenzie AN. Fallon PG, et al. Among authors: barlow jl. J Exp Med. 2006 Apr 17;203(4):1105-16. doi: 10.1084/jem.20051615. Epub 2006 Apr 10. J Exp Med. 2006. PMID: 16606668 Free PMC article.

3

Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma.

Ballantyne SJ, Barlow JL, Jolin HE, Nath P, Williams AS, Chung KF, Sturton G, Wong SH, McKenzie AN. Ballantyne SJ, et al. Among authors: barlow jl. J Allergy Clin Immunol. 2007 Dec;120(6):1324-31. doi: 10.1016/j.jaci.2007.07.051. Epub 2007 Sep 24. J Allergy Clin Immunol. 2007. PMID: 17889290

4

The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.

Saunders SP, Walsh CM, Barlow JL, Mangan NE, Taylor PR, McKenzie AN, Smith P, Fallon PG. Saunders SP, et al. Among authors: barlow jl. Infect Immun. 2009 Jan;77(1):399-404. doi: 10.1128/IAI.00762-08. Epub 2008 Nov 3. Infect Immun. 2009. PMID: 18981244 Free PMC article.

5

IL-25: a key requirement for the regulation of type-2 immunity.

Barlow JL, McKenzie AN. Barlow JL, et al. Biofactors. 2009 Mar-Apr;35(2):178-82. doi: 10.1002/biof.24. Biofactors. 2009. PMID: 19449446 Review.

6

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.

Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL, Jolin HE, Pannell R, Middleton AJ, Wong SH, Warren AJ, Wainscoat JS, Boultwood J, McKenzie AN. Barlow JL, et al. Nat Med. 2010 Jan;16(1):59-66. doi: 10.1038/nm.2063. Epub 2009 Nov 22. Nat Med. 2010. PMID: 19966810 Free PMC article.

7

C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide.

Saunders SP, Barlow JL, Walsh CM, Bellsoi A, Smith P, McKenzie AN, Fallon PG. Saunders SP, et al. Among authors: barlow jl. J Immunol. 2010 Mar 1;184(5):2627-37. doi: 10.4049/jimmunol.0901970. Epub 2010 Feb 3. J Immunol. 2010. PMID: 20130211

8

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.

Pellagatti A, Marafioti T, Paterson JC, Barlow JL, Drynan LF, Giagounidis A, Pileri SA, Cazzola M, McKenzie AN, Wainscoat JS, Boultwood J. Pellagatti A, et al. Among authors: barlow jl. Blood. 2010 Apr 1;115(13):2721-3. doi: 10.1182/blood-2009-12-259705. Blood. 2010. PMID: 20360478 Free article. No abstract available.

9

Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response.

Wong SH, Barlow JL, Nabarro S, Fallon PG, McKenzie AN. Wong SH, et al. Among authors: barlow jl. Immunology. 2010 Sep;131(1):77-88. doi: 10.1111/j.1365-2567.2010.03276.x. Epub 2010 May 26. Immunology. 2010. PMID: 20518819 Free PMC article.

10

New insights into 5q- syndrome as a ribosomopathy.

Barlow JL, Drynan LF, Trim NL, Erber WN, Warren AJ, McKenzie AN. Barlow JL, et al. Cell Cycle. 2010 Nov 1;9(21):4286-93. doi: 10.4161/cc.9.21.13742. Epub 2010 Nov 22. Cell Cycle. 2010. PMID: 20980806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters